8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Join Veristat and nearly 2,500 professionals from biotech, pharma, finance and life sciences industry across Europe’s most innovative biopharma clusters at the Bio Europe Spring 2017 event.
![]()
March 20–22, 2017
CCIB Convention Centre, Barcelona, Spain
Veristat really enjoys helping small firms grow as they advance thier single product or even small pipeline of products through the clinical development and regulatory submission process. Consider meeting us at BioEurope Spring to discuss your current programs and tell us about the current challenges you are facing.
Learn how we've helped a current client as they grew not only thier company, but took thier product through the development process:
A Case Study | How Veristat Helps Growing Biotech Firms
A current client started working with Veristat over 6 years ago as a small venture funded biotech firm. Our initial engagement began with strategic consulting for their clinical development program and representation at numerous agency meetings (EMA & FDA), which has evolved over time to running over 15 studies. We helped them as they grew from a 4 person to a 300 person firm. Today, we remain a preferred provider and are working on thier submission for the original product that we helped them with.
To meet up with Veristat at this event, connect with us through the conference partnering system or fill out the form on the right side of this page.
We look forward to meeting you in Barcelona!
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...